Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microbial colonization and atopic dermatitis.

Antonie Roll1, Antonio Cozzio, Barbra Fischer

  • 1Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland.

Current Opinion in Allergy and Clinical Immunology
|September 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis.

International journal of dermatology·2026
Same author

Noninvasive Imaging Modalities for Evaluating Patch Testing: A Systematic Review.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paper.

The World Allergy Organization journal·2026
Same author

Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.

The Journal of allergy and clinical immunology·2026
Same author

Contact Urticaria to Chamois ( Rupicapra rupicapra ) Raw Muscle Meat in a Non-Occupational Hunter: First Documented Case.

Contact dermatitis·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Microbial colonization, particularly Staphylococcus aureus, significantly worsens atopic dermatitis by modulating immune responses. Understanding these triggers offers new therapeutic avenues beyond anti-inflammatory treatments for this common skin condition.

Area of Science:

  • Immunology
  • Dermatology
  • Microbiology

Background:

  • Atopic dermatitis is a prevalent chronic skin inflammation affecting millions globally.
  • Its prevalence is increasing, especially in industrialized nations.
  • Microbial colonization is increasingly recognized as a key factor in atopic dermatitis.

Purpose of the Study:

  • To review studies on immunological triggers in atopic dermatitis since June 2002.
  • To emphasize the role of microbial colonization in the disease.

Main Methods:

  • Review of scientific literature published since June 2002.
  • Focus on studies investigating immunological triggers and microbial involvement.

Main Results:

Related Experiment Videos

  • Staphylococcus aureus exacerbates atopic dermatitis by producing superantigens that drive T cell proliferation and a Th2-like cytokine profile.
  • Malassezia species may elicit and sustain skin inflammation, though precise mechanisms require further elucidation.
  • Microorganisms are implicated in sustained disease activity and therapeutic resistance through immune modulation.

    • Conclusions:

    • New understanding of microbial immunomodulatory pathways in atopic dermatitis is crucial.
    • Therapeutic strategies may evolve to include treatments targeting microbial factors.
    • Patients might benefit from combined anti-inflammatory and immunomodulatory treatments in the future.